Đang chuẩn bị liên kết để tải về tài liệu:
HIV Medicine - part 4

Tóm tắt WeOaLB0102, 3 IAS năm 2005, Rio de Janeiro. Katlama C, Dominguez S, Duvivier C, et al. Lợi ích của việc gián đoạn điều trị ở những bệnh nhân với nhiều thất bại điều trị, các tế bào CD4 50 000 cp / ml. Tóm tắt 5887, XIV Int AIDS Conf 2002, Barcelona. Katlama C, Dominguez S, Gourlain K, et al. Lợi ích của sự gián đoạn điều trị trong bệnh nhân nhiễm HIV với nhiều thất bại điều trị | 250 ART 2006 29. Katlama C Carvalho MI Cooper D et al. TMC 114 r out performs investigator selected PI s in three class-experienced patients week 24 primary analysis of POWER 1 TMC 114-C213 . Abstract WeOaLB0102 3rd IAS 2005 Rio de Janeiro. 30. Katlama C Dominguez S Duvivier C et al. Benefits of treatment interruption in patients with multiple therapy failures cD4 cells 200 mm3 and HIV RNA 50 000 cp ml. Abstract 5887 XIV Int AIDS Conf 2002 Barcelona. 31. Katlama C Dominguez S Gourlain K et al. Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures a randomized controlled trial ANRS 097 . AIDS 2004 18 217-26. http amedeo.com p2.php id 15075539 s hiv 32. Kempf DJ Isaacson JD King MS et al. Identification of genotypic changes in HIV protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients. J Virol 2001 75 7462-9. http amedeo.com lit.php id 11462018 33. Khanlou H Farthing C. Favorable interaction between atazanavir and fosamprenavir with and without ritonavir in the treatment of HIV-infected patients. Abstract P288 7th Int Congress Drug Ther HIV Inf 2004 Glasgow. 34. Khanlou H Graham E Farthing C. Drug interactions between amprenavir and lopinavir ritonavir in salvage therapy. AIDS 2002 16 797-798. 35. Klein C Bertz R Ashbrenner E et al. Assessment of the multiple-dose pharmacokinetic interaction of lopinavir ritonavir with nelfinavir. Abstract 536 10th CROI 2003 Boston. 36. la Porte CJ Schippers EF van der Ende ME et al. Pharmacokinetics of once-daily lopinavir ritonavir and the influence of dose modifications. AIDS 2005 19 1105-7. http amedeo.com lit.php id 15958844 37. Lalezari JP Henry K O Hearn M et al. Enfuvirtide an HIV-1 fusion inhibitor for drug-resistant HIV infection in North and South America. N Engl J Med 2003 348 2175-85. http amedeo.com lit.php id 12637625 38. Langmann P Zilly M Winzer R et al. Efficacy and safety of ATV